1995
DOI: 10.1001/archotol.1995.01890030025005
|View full text |Cite
|
Sign up to set email alerts
|

Production by Human Squamous Cell Carcinoma of a Factor Inducing Activation and Proliferation of Immune Cells

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1
1

Citation Types

0
5
0

Year Published

1996
1996
2003
2003

Publication Types

Select...
7
1

Relationship

0
8

Authors

Journals

citations
Cited by 9 publications
(5 citation statements)
references
References 21 publications
0
5
0
Order By: Relevance
“…PCI-51, a human head and neck squamous cell carcinoma (SCC) cell line, was established in our laboratory as previously described (Hirabayashi et al, 1995). K562, a human NK-sensitive cell line, derived from a patient with chronic myelogenous leukaemia, was maintained as described (Vujanovic et al, 1995a).…”
Section: Cell Lines and Reagentsmentioning
confidence: 99%
“…PCI-51, a human head and neck squamous cell carcinoma (SCC) cell line, was established in our laboratory as previously described (Hirabayashi et al, 1995). K562, a human NK-sensitive cell line, derived from a patient with chronic myelogenous leukaemia, was maintained as described (Vujanovic et al, 1995a).…”
Section: Cell Lines and Reagentsmentioning
confidence: 99%
“…In addition, the T helper 1 (Th1) type cytokines cooperate with antigen-presenting cells in the induction of cytotoxic lymphocytes and upregulate the cytotoxic activity of TIL [11, 12]. TIL as well as cancer cells generate both Th1 type and T helper 2 (Th2) type cytokines, and the generated cytokines build an in situ cytokine network, influencing TIL and cancer cells and each other [13, 14, 15, 16, 17, 18]. However, the levels of cytokines generated by TIL and cancer cells have been infrequently examined, and the influence of cancer therapy on cytokine generation by TIL and cancer cells has not been well explored.…”
Section: Introductionmentioning
confidence: 99%
“…On one side, it was found that the lymphocytic secretion of some cytokines, in particular IL-2, was inhibited [6], while the secretion of other cytokines, i.e. IFN-Á, TNF-· and IL-6 by NK or T cells, were found to be enhanced by culture supernatants of different tumor cell lines [17]. On the other side, an insufficient production of IFN-Á by whole blood cultures from CRC and other tumor patients was also reported [3,4].…”
Section: Discussionmentioning
confidence: 99%